Redeye views positively the news that two Medicare Administrative Contractors (MACs) have updated th...
Administer reported H2 figures a notch above our expectations.
Redeye comments on Zordix announcement that CEO Christina Seelye has increased her ownership in Zord...
Tendo har presenterat ett intensivt nyhetsflöde under mars 2023, vilket skapar möjligheter för framt...
Scandion Oncology has announced that the Phase Ib PANTAX trial has concluded and reached its primary...
Q1 due Tuesday 25 April, 08:30 CET We expect strong orders but weak EBIT We reduce '23-'25e EBIT on ...
Q1 report due on Tuesday, 25 April Volatile weather should make for a soft quarter '23e trough earni...
Q1 report due on Thursday, 4 May Cost savings programme to show effect from Q2 onwards 13x '25e ABGS...
We expect a decent Q1 print driven by both divisions '23e-'25e adj.
Redeye provides an update on Fantasma Games ahead of its Q1-results (due 10 May), where we expect a ...
Marknadsföringsinvesteringar börjar bära frukt Nettoomsättningen i kvartalet uppgick till 96,1 mkr v...
Redeye endorses today's press release announcing that Ximluci is now being launched by STADA and Xbr...
Expect DKK 34m in sales and EBITDAC of DKK -19m 2023 will be an important year for product developme...
Redeye comments on the release of Smalland: Survive the Wilds which has seen a very strong start to ...
Redeye provides an update to Wyld Networks Q4 2022 report.
FirstFarms A/S (“FirstFarms” or “the Company”) is a Danish investment company in the agriculture sec...
Redeye is encouraged by PANTAX phase Ib top-line data aligning with our expectations.
Redeye comments on Coala Life’s Q4’22 report, in which sales increased by c80% over the previous qua...
Redeye is encouraged to see that interest in the PFAS challenge increases with more sectors looking ...
Yesterday, Egetis acknowledged that it has talks with certain external parties about a possible acqu...
